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Purpose: It was shown by several experimental studies that some G protein coupled receptors (GPCR) are sensitive
to sodium ions. Furthermore, mutagenesis studies or the determination of crystal structures of the adenosine A2A or
δ-opioid receptor revealed an allosteric Na+ binding pocket near to the highly conserved Asp2.50. Within a previous
study, the influence of NaCl concentration onto the steady-state GTPase activity at the human histamine H3 receptor
(hH3R) in presence of the endogenous histamine or the inverse agonist thioperamide was analyzed. The purpose of the
present study was to examine and quantify the Na+-sensitivity of hH3R on a molecular level.
Methods: To achieve this, we developed a set of equations, describing constitutive activity and the different
ligand-receptor equilibria in absence or presence of sodium ions. Furthermore, in order to gain a better
understanding of the ligand- and Na+-binding to hH3R on molecular level, we performed molecular dynamic
(MD) simulations.
Results: The analysis of the previously determined experimental steady-state GTPase data with the set of equations
presented within this study, reveals that thioperamide binds into the orthosteric binding pocket of the hH3R in absence
or presence of a Na+ in its allosteric binding site. However, the data suggest that thioperamide binds preferentially into
the hH3R in absence of a sodium ion in its allosteric site. These experimental results were supported by MD simulations
of thioperamide in the binding pocket of the inactive hH3R. Furthermore, the MD simulations revealed two different
binding modes for thioperamide in presence or absence of a Na+ in its allosteric site.
Conclusion: The mathematical model presented within this study describes the experimental data regarding the
Na+-sensitivity of hH3R in an excellent manner. Although the present study is focused onto the Na
+-sensitivity
of the hH3R, the resulting equations, describing Na
+- and ligand-binding to a GPCR, can be used for all other
ion-sensitive GPCRs.
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G protein coupled receptors (GPCRs), one of the largest
protein families within the human genome, play an im-
portant role in several physiological and pathophysio-
logical processes (Wise et al. 2002; Foord et al. 2005;
Jacoby et al. 2006). In general, the two-state model of
GPCR activation suggests that GPCRs can exist in two
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in any medium, provided the original work is p(Schütz and Freissmuth 1992; Lefkowitz et al. 1993; Leff
1995; Seifert and Wenzel-Seifert 2002). These two differ-
ent conformations were confirmed by crystal structures
of the inactive and active state of the β2-adrenergic re-
ceptor (Cherezov et al. 2007; Rosenbaum et al. 2009;
Rasmussen et al. 2011). Ligands, addressing GPCRs, can
be classified as inverse agonists, neutral antagonist or
agonists (Seifert and Wenzel-Seifert 2002, 2003). It is
assumed that inverse agonists stabilize the inactive,
whereas agonists stabilize the active state of GPCRs
(Seifert and Wenzel-Seifert 2002, 2003). The histamine
H3 receptor (H3R), identified in the early 1980s, is one
of four histamine receptor subtypes and belongs to the
aminergic GPCRS (Hill et al. 1997; Lovenberg et al.is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly cited.
Figure 1 Sodium sensitivity oh hH3R. A, Structures of histamine
and thioperamide. B, Influence of sodium ions onto the hH3R,
determined in the steady state GTPase assay. (Figure was adopted
from Schnell and Seifert (2010).
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H3R regulates the release of the endogenous histamine
and other neurotransmitters in the nervous system and
is involved in important physiological processes, e.g.
cognition, eating-behaviour and the sleep-wake cycle
(Leurs et al. 2005). For the hH3R, a large number of
ligands is known (Sasse et al. 2000; Stark et al. 2001;
Schnell and Seifert 2010; Strasser et al. 2013; Seifert
et al. 2013). However, thioperamide is a standard inverse
agonist at the hH3R (Arrang et al. 1987; Schnell and Seifert
2010). Some GPCRs, showing constitutive activity, change
its conformation from the inactive into the active state in
absence of an agonist (Seifert and Wenzel-Seifert 2002,
2003). It was shown that the hH3R and the highly related
hH4R exhibit constitutive activity (Morisset et al. 2000;
Schneider et al. 2009; Schnell et al. 2010). Experimental
studies revealed that sodium ions can act as an allosteric
modulator and stabilize the inactive conformation of a
GPCR (Seifert and Wenzel-Seifert 2002, 2003). Experi-
mental studies revealed that only distinct GPCRs are
sensitive for sodium ions, whereas other GPCRs are in-
sensitive for sodium ions. The neurotensine receptors
(Martin et al. 1999), the D2 (Neve 1991; Schetz 2005;
Ericksen et al. 2009) for example, are sodium sensitive.
Within the family of the histamine receptors, the hH3R
is sodium sensitive (Schnell and Seifert 2010) whereas
the highly related hH4R is sodium insensitive (Schneider
and Seifert 2009). The corresponding allosteric sodium
ion binding site is located between TM II, TM III and
TM VII near to the highly conserved Asp2.50, as was
shown recently with the crystal structure of the human
adenosine A2A receptor (hA2AR) (Liu et al. 2012) or the
δ-opioid receptor (Fenalti et al. 2014). The location of
the allosteric sodium binding site was also supported
by mutagenesis of the highly conserved Asp2.50 into the
neutral alanine (Neve et al. 1991; Schetz and Sibley
2001) or asparagine (Ceresa and Limbird 1994; Schnell
and Seifert 2010). This is supported by experimental
results at hH3R, where the Asp
2.50Asn mutant was
found to partially mimic the effect of high sodium
chloride concentrations by suppressing constitutive ac-
tivity (Schnell and Seifert 2010). With MD studies the
binding pathway of a sodium ion into the allosteric
sodium binding site of the D2 receptor (Selent et al.
2010) and the μ-opioid receptor (Yuan et al. 2013) were
observed.
During the last decades, several theoretical models were
established to explain receptor function quantitatively
(Leff 1995; Leff et al. 1997; Christopoulos and Kenakin
2002; Kenakin 2004; Langmead and Christopoulos 2006;
Kenakin 2013). Those basic concepts can be extended
to describe ion-sensitivity of GPCRs. Within a previous
study of Schnell and Seifert (2010), the influence of
NaCl concentration onto the concentration responsecurves of the endogenous histamine and the inverse
agonist thioperamide onto the hH3R were investigated
(Figure 1). Within the present study, we developed a set
of equations, describing constitutive activity and the dif-
ferent ligand-receptor equilibra in presence or absence
of sodium ions. Furthermore, we used the experimental
data, published by Schnell and Seifert (2010) previously
(Figure 1) for determination of the equilibrium constants,
described by the set of equations, mentioned above, e.g.
constants regard to constitutive activity, binding of a
sodium ion to the receptor, and binding of histamine
or thioperamide to the hH3R in absence or presence of
sodium ions. Furthermore, MD simulations of several
inactive thioperamide-Na+-hH3R-complexes were per-
formed. These simulations showed that thioperamide
can bind into the orthosteric site of hH3R in presence
or absence of the Na+ in the allosteric pocket, resulting
in different binding modes of thioperamide.Methods
Equations
For the quantitative description of the sodium sensitivity
of the hH3R, ten different mass action laws describing
the formation of different ligand-receptor complexes
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perimentally observed constitutive activity of the ligand
free receptor according to the equilibrium R ⇌ R*:
K0 ¼ R

R
ð1Þ
Therein, R* represents the ligand- and sodium free-
active receptor and R the ligand- and Na+- free inactive
receptor.
Additionally, distinct Na+-receptor equilibriums have
to be considered: Equation (2) describes the equilibrium
between the inactive receptor R and the inactive recep-
tor containing a sodium ion in the orthosteric ligand
binding pocket denoted by AorthoR according to A + R ⇌
AorthoR. Therein, the concentration of sodium chloride A
is considered to be equal to the overall concentration A0
of sodium chloride, because of the much smaller con-
centration of the receptor species. This approximation
holds also for the ligands thioperamide (B) and hista-
mine (C).
K1 ¼ A
orthoR
Ao⋅R
ð2Þ
In general, it has to be taken into account (equation 3)
that sodium ions are able to bind into the orthosteric
binding pocket of the active receptor establishing the
complex AorthoR* according to A + R* ⇌ AorthoR*:
K2 ¼ A
orthoR

A0⋅R
 ð3Þ
Based on experimental studies, it is suggested that a
sodium ion A can bind from its orthosteric into its
allosteric binding pocket to form the species AalloR ac-
cording to AorthoR ⇌ AalloR. This fact is considered in
equation 4.
K3 ¼ A
alloR
AorthoR
ð4Þ
Additionally in the presence of thioperamide marked
by B, the following equations (5, 6, 7) have to be consid-
ered. Thioperamide B can bind into the orthosteric ligand
binding site of the inactive receptor and a corresponding
thioperamide-receptor complex BR is formed (equation 5)
according to B + R⇌ BR.
K4 ¼ BRB0⋅R ð5Þ
There, B0 represents the total concentration of thio-
peramide. Furthermore, it has to be taken into account
that thioperamide may also be able to bind into the
orthosteric ligand binding site of the active receptor
(equation 6) and a corresponding active thioperamide-receptor complex BR* is formed according to B + R* ⇌
BR*.
K5 ¼ BR

B0⋅R
 ð6Þ
Next, it has to be considered that thioperamide binds
into the orthosteric binding site when a sodium ion is
bound into the allosteric binding site of the inactive re-
ceptor (equation 7) forming the complex BAalloR accord-
ing to B + AalloR ⇌ BAalloR.
K6 ¼ BA
alloR
B0⋅AalloR
ð7Þ
In case that histamine C is present, the equations (8, 9,
10) have to be taken into account. In general it should
be considered that histamine C is able to bind into the
orthosteric ligand binding site of the inactive receptor
(equation 8) and a corresponding histamine-receptor
complex CR is formed according to C + R⇌ CR:
K7 ¼ CRC0⋅R ð8Þ
where C0 describes the total concentration of histamine.
Furthermore, it has to be taken into account that hista-
mine binds into the orthosteric ligand binding site of the
active receptor (equation 9) and a corresponding active
histamine-receptor complex CR* is formed according to
C + R* ⇌ CR*:
K8 ¼ CR

C0⋅R
 ð9Þ
Additionally, it has to be expected that histamine
binds into the orthosteric binding site when a sodium
ion is bound into the allosteric binding site (equation 10)
of the inactive receptor CAalloR at the same time accord-
ing to C +AalloR ⇌ CAalloR:
K9 ¼ CA
alloR
C0⋅AalloR
ð10Þ
It is suggested that sodium ions are not able to bind
into the allosteric binding site of the active receptor (Liu
et al. 2012). Therefore, the corresponding complexes are
not considered within the presented system of equations.
Once more, it should be mentioned that the overall con-
centrations of sodium chloride, thioperamide and hista-
mine (eqs. 2, 3, 4, 5, 6, 7, 8, 9 and 10) are much higher
than the total concentration of the receptor, so no
change of that quantities will be detected when reaching
the thermodynamic equilibrium. Equation (11) results
from the law of conservation of matter referring to the
receptor.
Wittmann et al. In Silico Pharmacology 2014, 2:1 Page 4 of 14
http://www.in-silico-pharmacology.com/2/1/1R0 ¼ Rþ R þ AorthoRþ AorthoR þ AalloR
þ BRþ BR þ BAalloRþ CRþ CR
þ CAalloR ð11Þ
The solution of the equations 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
and 11 with respect to the concentration terms was
calculated using the software package MAPLE 11.0
(Maplesoft Waterloo Maple Inc. 1981-2007). Maple is
a computer algebra system, allowing users to define
mathematical equations in a simple manner, solve these
equations with one command line and plot the corre-
sponding results. To elucidate this, the definition of
equations (1, 2, 3, 4, 5, 6, 7, 8, 9, 10 and 11) (see the fol-
lowing command lines e1 to e11) and their solution with
the help of the command “solve” (see command line
e12) is shown, using the Maple syntax:
> e1:=K0 = RS/R:
> e2:=K1 = AR/(A0*R):
> e3:=K2 = ARS/(A0*RS):
> e4:=K3 = ARR/AR:
> e5:=K4 = BR/(B0*R):
> e6:=K5 = BRS/(B0*RS):
> e7:=K6 = BRR/(B0*ARR):
> e8:=K7 = CR/(C0*R):
> e9:=K8 = CRS/(C0*RS):
> e10:=K9 = CRR/(C0*ARR):
> e11:=R0 = R + RS + AR + ARS + ARR + BR + BRS +
BRR + CR + CRS + CRR:
> e12:=solve({e1,e2,e3,e4,e5,e6,e7,e8,e9,e10,e11},{R,RS,
AR,ARS,ARR,BR,BRS,BRR,CR,CRS,CRR});
The last command led to the following expressions for
the concentration terms (Maple notation in brackets) R
(R), R* (RS), AorthoR (AR), AorthoR* (ARS), AalloR (ARR),
BR (BR), BR* (BRS), BAalloR (BRR), CR (CR), CR* (CRS)
and CAalloR (CRR):
The denominator d of the following terms reads as:
d ¼ 1þ K 0 þ K 1A0 þ K 4B0 þ K 7C0 þ K 0K2A0
þK1K3A0 þ K 0K 5B0 þ K 0K 8C0 þ K1K3K 6A0B0
þK1K 3K 9A0C0
ð12Þ
R ¼ R0
d
ð13Þ
R ¼ K 0R0
d
ð14Þ
AorthoR ¼ K1A0R0
d
ð15Þ
AorthoR ¼ K 0K2A0R0
d
ð16ÞAalloR ¼ K1K 3A0R0
d
ð17Þ
BR ¼ K4B0R0
d
ð18Þ
BR ¼ K0K5B0R0
d
ð19Þ
BAalloR ¼ K 1K3K6A0B0R0
d
ð20Þ
CR ¼ K 7C0R0
d
ð21Þ
CR ¼ K0K8C0R0
d
ð22Þ
CAalloR ¼ K1K3K 9A0C0R0
d
ð23Þ
Description of the efficacy
The efficacy determined by steady-state GTPase assay is
assumed to be proportional (described by factor f, as-
suming that f is independent of any concentration) to all
complexes containing an active receptor configuration
(equation 24):
E ¼ f ⋅ R þ AR þ BR þ CR  ð24Þ
To introduce the constants K0 to K9 in equation 24,
the equations 14, 16, 19 and 22 can be introduced into
24, leading to the following equation 25:
E ¼ f R0K0 1þ K 2A0 þ K 5B0 þ K 8C0ð Þ
d
ð25Þ
The application of the present mathematical concept
onto experimental data values requires to define a refer-
ence value Eref of the effect E: Eref (equation 26) repre-
sents the effect at A0 = B0 = 0 and C0
ref = 10 μM and is
obtained from equation 25:
Eref ¼
f R0K0 1þ K 8Cref0
 
1þ K0 þ K7Cref0 þ K 0K8Cref0
ð26Þ
The resulting relative quantity Erel (equation 27) corre-
sponds directly to the experimental data (Schnell and
Seifert 2010) shown in Figure 1.
Erel ¼ EEref
¼ 1þ K2A0 þ K 5B0 þ K 8C0ð Þð1þ K0K 7C
ref
0 þ K 0K 8Cref0 Þ
d⋅ð1þ K 8Cref0 Þ
ð27Þ
Thus, if only thioperamide (B) and sodium ions (A)
are present, equation 27 can be written as
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ref
0 þ K0K8Cref0 Þ
ð1þ K0 þ K1A0 þ K4B0 þ K0K2A0 þ K1K3A0
þK0K5B0 þ K1K3K6A0B0Þð1þ K8Cref0 Þ
ð28Þ
and if only histamine (C) and sodium ions (A) are
present, as
Erel ¼ 1þ K2A0 þ K8C0ð Þð1þ K0K7C
ref
0 þ K0K8Cref0 Þ
ð1þ K0 þ K1A0 þ K7C0 þ K0K2A0 þ K1K3A0 þ K0K8C0
þK1K3K9A0C0Þð1þ K8Cref0 Þ
ð29Þ
Least-square fit to obtain the constants Kx
To determine the constants Kx (K0 to K9) the software
MAPLE 11.0 was used. For fitting of the experimental
data (Schnell and Seifert 2010), equation 27 was used,
where the constants Kx were substituted by Kx = 10
pKx.
The least-square fit is based on the following equation 30,
describing the deviance s2:
s2 ¼
X
i
Erelexp;i−E
rel
calc;i
 2
ð30Þ
There, Erelexp;i represents each experimentally deter-
mined data point i shown in Figure 1, relative to the ef-
fect, determined at a histamine concentration of C0
ref =
10 μM in absence of sodium chloride and thioperamide.
Erelcalc;i represents the calculated relative effect according to
equation 25 for a set of constants Kx to be determined by
searching the minimum of s2 using the software MAPLE
11.0. However, to solve this problem, every other software
package can be used.
Construction of the inactive model of hH3R
For the construction of the homology model of the
inactive hH3R, the crystal structure of the inactive hH1R
(3RZE) (Shimamura et al. 2011) was used as a template.
The hH3R homology model was designed using SYBYL
7.0 (Tripos; http://www.tripos.com) according to a
protocol, described previously (Strasser and Wittmann
2013; Darras et al. 2014; Wagner et al. 2014). Briefly,
the artificial lysozyme in 3RZE was deleted and the
homology model was generated according to a hH1R-
hH3R amino acid alignment already described (Strasser
et al. 2013). The N-terminus, missing in the crystal
structure of hH1R, was completed using SYBYL 7.0
(Tripos Inc), as described previously (Darras et al.
2014; Wagner et al. 2014). Furthermore, the E2-loop
was completed using the “Loop-Search” module of
SYBYL 7.0, as described previously for the hH4R
(Darras et al. 2014; Wagner et al. 2014). Because there
is no information about the conformation of the longI3-loop of the hH3R, containing more than 100 amino
acids, the amino acids Ala239 to Arg347 were not in-
cluded into the model. However, to close the resulting
gap between TM V and TM VI on the intracellular
side, eight alanines were inserted instead. It was shown
previously, that internal water molecules play an im-
portant role in stabilization or activation of aminergic
GPCRs (Angel et al. 2009; Liu et al. 2012). Therefore,
the internal water molecules, described in literature
were included according to the corresponding crystal
structures (Angel et al. 2009; Liu et al. 2012). In a first
model, thioperamide was docked manually into the
binding pocket of hH3R, in such manner that the posi-
tively charged imidazole moiety interacts electrostati-
cally with the highly conserved Asp3.32, according to
the binding mode for analogue compounds, already de-
scribed in literature (Schnell and Seifert 2010). The
remaining part of thioperamide was embedded in a
pocket between TM III, TM V and TM VI, as already
described for similar H3 receptor ligands (Schlegel
et al. 2007; Schnell and Seifert 2010). In a second
model, one sodium ion was docked manually into the
allosteric binding site of hH3R, according to the crystal
structure of the A2A with a Na
+ in the allosteric bind-
ing site (Liu et al. 2012). Furthermore, a third model,
containing thioperamide in the orthosteric and one so-
dium ion in the allosteric binding site was constructed,
as described above for the thioperamide- and the
sodium-ion- model. The resulting complexes were mini-
mized energetically with SYBYL 7.0. Subsequently the
minimized hH3R-models containing thioperamide and/
or a sodium ion were embedded in a POPC lipid bilayer.
Afterwards, intracellular and extracellular water mole-
cules were added. To achieve electroneutrality, an ap-
propriate number of sodium ions and chloride ions
were added into the simulation box. Subsequently, MD
simulations were performed with GROMACS 4.0.2
(http://www.gromacs.org) as already described (Strasser
et al. 2008; Igel et al. 2009; Darras et al. 2014). The
parameterization for thioperamide was obtained from
the PRODRG server (http://davapc1.bioch.dundee.ac.
uk/prodrg/). However, the partial charges were adopted
by the Gasteiger-Hückel partial charged, calculated with
SYBYL 7.0. The force field parameters for the POPC
lipids were obtained from the online source http://
moose.bio.ucalgary.ca/index.php?page=Structures_and_
Topologies. For equilibration, a 5 ns MD simulation
was performed: Within the first 2.5 ns, force constants
of 250 kJ/(mol nm2) were put onto the backbone atoms
of the TM domains of hH3R, within the second 2.5 ns,
these force constants were reduced to 100 kJ/(mol nm2).
Subsequently, 10 ns up to 35 ns productive phase of
simulations were performed, without using any force
constants.
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Constants K0 to K9 for the hH3R, determined by steady-
state GTPase assays
The nonlinear least square fit was used to determine the
constants K0 to K9 (Kx), expressed as the corresponding
values pK0 – pK9 (pKx) , using the definition Kx = 10
pKx,
as described under Materials and Methods (Table 1).
The constant K0, describing the constitutive activity
has a value of 0.92. Thus, the active hH3R (R*) is de-
creased in stability of ΔRG
o = 0.21 kJ/mol compared to
the inactive hH3R (R) (Table 1) according to R⇌ R*.
The binding of a sodium ion from the aqueous extra-
cellular side into the allosteric binding site can be di-
vided into two steps, according to the equations 2 and 4.
The binding of the Na+ into the orthosteric binding
site (AorthoR) according to A + R ⇌ AorthoR with an asso-
ciation constant K1 of 2.08 is energetically favoured
(ΔRG
o = -1.76 kJ/mol) (Table 1). The subsequent binding
of the sodium ion from the orthosteric into the allosteric
binding site, with a K3 of 11.98, according to A
orthoR ⇌
AalloR, is energetically favoured with ΔRG
o = -6.10 kJ/mol
(Table 1). Thus, the consecutive binding process of the
sodium ion into its allosteric binding site, according
to A + R ⇌ AorthoR, is energetically favoured with
ΔRG
o = -7.86 kJ/mol. The binding of a sodium ion into
the orthosteric binding site of the active hH3R, accord-
ing to A + R* ⇌ AorthoR*, with ΔRG
o = -0.33 kJ/mol
does not differ significantly from zero (Table 1).
The binding of thioperamide to the orthosteric binding
site of hH3R in absence of a sodium ion in the allosteric
binding site is preferred compared to the binding in
presence of a sodium ion in the allosteric binding site, as
indicated by the corresponding association constants
K4, according to B + R ⇌ BR, and K6, according to B +
AalloR ⇌ BAalloR. The association constant K5 for the
binding of thioperamide to the active state hH3R, ac-
cording to B + R* ⇌ BR* is smaller than K4 or K6Table 1 pKx, Kx and ΔRG
o values, describing the constitutive a
histamine to hH3R
x
Constitutive activity 0 R ⇌ R*
NaCl (≡A) 1 A + R ⇌ AorthoR
2 A + R*⇌ AorthoR*
3 AorthoR ⇌ AalloR
THIO (≡B) 4 B + R ⇌ BR
5 B + R*⇌ BR*
6 B + AalloR ⇌ BAalloR
HIS (≡C) 7 C + R ⇌ CR
8 C + R*⇌ CR*
9 C + AalloR ⇌ CAalloR
The data were obtained by a least-square fit of experimental data (Schnell and Seif(Table 1), which is in good accordance to the experimen-
tal findings that thioperamide acts as an inverse agonist
at hH3R (Schnell and Seifert 2010).
To explain the different amounts of BR and BAalloR
Figure 2 represents the Gibbs energy (ΔRG
o) profile for the
processes A+B + R ⇌ A+BR and B +AalloR⇌ BAalloR.
The quantity ΔRG
o for the latter process is disfavoured
compared to the first one. Nevertheless, the concentration
of the complex BAalloR is higher than that of the
complex BR. The reason for this fact are the two pre-
ceding processes A + B + R ⇌ B + AorthoR and B +
AorthoR ⇌ B + AalloR resulting in a stabilization of the
complex BAalloR, representing thioperamide in the in-
active hH3R with Na
+ present in its allosteric binding
site (Figure 2).
The association constant K8 of the endogenous agonist
histamine to the active hH3R, according to C + R* ⇌
CR*, is higher than for the binding to the inactive hH3R
in absence (K7) or presence (K9) of a sodium ion in the
allosteric binding site (Table 1). This is in good accord-
ance to the experimental findings revealing histamine as
an agonist at hH3R (Schnell and Seifert 2010).
Relative concentration profiles of different receptor
complexes in dependence of thioperamide, histamine
and NaCl in the steady-state GTPase assay at hH3R
The relative concentration profiles (Figure 3) of the dif-
ferent species mentioned above, as function of concen-
trations of thioperamide, histamine and sodium chloride
were calculated based on the association constants,
given in Table 1. In absence or presence of 100 mM
NaCl, the amount of the ligand- and Na+-free receptor
states R* and R decreases to zero with increasing concen-
tration of thioperamide (Figure 3). The amount of BR
(inactive thioperamide-hH3R-complex without Na
+) and
BR* (active thioperamide-hH3R-complex without Na
+) in-
creases in absence of sodium chloride with increasingctivity, the binding of sodium ions, of thioperamide and
pKx ± S.E.M. Kx ± S.E.M. ΔRG
o [kJ/mol]
-0.04 ± 0.01 0.92 ± 0.03 0.21 ± 0.08
0.31 ± 0.03 2.08 ± 0.20 -1.76 ± 0.20
0.06 ± 0.08 1.29 ± 0.22 -0.33 ± 0.47
1.07 ± 0.04 11.98 ± 0.84 -6.10 ± 0.21
7.40 ± 0.03 2.56 · 107 ± 1.35 · 106 -42.25 ± 0.15
7.01 ± 0.03 1.03 · 107 ± 6.15 · 105 -39.98 ± 0.17
7.23 ± 0.03 1.71 · 107 ± 9.96 · 105 -41.25 ± 0.15
7.48 ± 0.01 3.05 · 107 ± 1.07 · 106 -42.71 ± 0.08
7.86 ± 0.01 7.20 · 107 ± 1.71 · 106 -44.84 ± 0.06
6.98 ± 0.01 9.48 · 106 ± 3.02 · 105 -39.81 ± 0.08
ert 2010), as described under Materials and Methods.
Figure 2 Gibbs energies (ΔRG
O) according to the constants Kx,
obtained by fitting experimental data. Schematic Gibbs energy
(ΔRGO) profile for the processes A + B + R⇌ A + BR (left branch) and
A + B + R ⇌ B + AorthoR ⇌ B + AalloR⇌ BAalloR (right branch) based
on the experimentally determined Kx values (Table 1).
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of BR* is smaller than of BR, which is in good accordance
to the experimental findings that thioperamide is an inverse
agonist (Schnell and Seifert 2010). Based on these data it
has to be suggested that thioperamide binds not only to the
inactive hH3R but also to the active state hH3R (Table 1).
Consequently, thioperamide has to be defined as a partial
inverse agonist. To support these results, analogousFigure 3 Concentration profiles of different Na+- or ligand-hH3R comp
were calculated according to the equations 13, 14, 15, 16, 17, 18, 19, 20, 21
experimental data of Schnell and Seifert 2010, shown in Figure 1, as describcalculations, but without including equation 6 and re-
lated variables were not able to fit the experimental
data. With increasing concentrations of sodium chlor-
ide, the amount of BAalloR increases, whereas the
amount of BR decreases. At a concentration of about
62 mM, the relative concentrations of BR and BAalloR
are identical. Thus, at concentrations of sodium chloride
< 62 mM, the relative concentration of BR is larger than of
BAalloR, whereas at concentrations of sodium chloride
> 62 mM, the relative concentration of BR is smaller than
of BAalloR. The latter case is presented for a concentration
of sodium chloride of 100 mM in Figure 3: There, the
amount of BAalloR is about factor 1.5 higher than the
amount of BR.
In absence or presence of 100 mM NaCl, the amount
of the ligand- and Na+-free receptor states R* and R de-
creases to zero with increasing concentrations of hista-
mine whereas the amount of CR* increases (Figure 3).
However, regardless of the sodium chloride concentra-
tion, a small amount of the Na+-free inactive histamine-
hH3R-complex (CR) is present. With increasing concen-
tration of sodium chloride, the amount of CAalloR
increases. At a concentration of about 285 mM of NaCl,
the concentrations of CR* and CAalloR are nearly equal.
For all concentrations of sodium chloride less than
285 mM, CR* is higher than CAalloR (Figure 3). Based
on these data it has to be suggested that histamine binds
also in the inactive state hH3R with or without Na
+
bound in its allosteric binding site. However, histamine
is defined as a full agonist, because there is no other lig-
and with higher stimulatory effect than histamine at
hH3R. To support these results, analogue calculations,lexes in absence or presence of NaCl. The concentration profiles
, 22 and 23, using the constants Kx (Table 1), obtained by fitting of the
ed in Materials and Methods.
Figure 5 Portion of R*, AorthoR* and BR* or CR*, in dependence
of NaCl concentration in GTP hydrolysis and the resulting
steady-state GTPase course. The profiles were calculated
according to equation 27 using the constants Kx (Table 1), obtained
by fitting of the experimental data of Schnell and Seifert 2010,
shown in Figure 1, as described in Materials and Methods.
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variables were performed, but were not able to fit the ex-
perimental data. However, in presence of 100 mM NaCl,
the concentration of CR* is about 3 times higher than
that of CAalloR (Figure 3).
Explanation of the steady-state GTPase results for the hH3R
In general, it is suggested that only active hH3R com-
plexes induce GTPase activity. Thus, to explain the re-
sults of the steady-state GTPase assay at hH3R, the
complexes R*, AorthoR* and BR* in case of thioperamide
and R*, AorthoR* and CR* in case of histamine have to
be considered. The sum of these values results in the
experimentally determined course of GTPase activity
(Figures 4 and 5). Figure 4 shows that the experimentally
observed courses within the steady-state GTPase assay
for thioperamide or histamine in absence or presence of
100 mM NaCl at hH3R, are the sum of at least two dif-
ferent courses, namely R* and BR* (in case of thiopera-
mide) and R* and CR* (in case of histamine). The third
complex, AorthoR*, is zero in absence of NaCl or nearly
zero in presence of 100 mM NaCl. The data for thioper-
amide (Figure 4) show that the contribution of R* to the
GTPase activity decreases with increasing thioperamide
concentration. In contrast, the contribution of the active
thioperamide-hH3R-complexes (BR*) to the GTPase ac-
tivity increases (Figure 4). But because the increase of
BR* is not as strong as the decrease of R*, the final
GTPase activity is decreased with increasing thiopera-
mide concentration, which is in very good accordance to
experimental results (Schnell and Seifert 2010). The data
for histamine (Figure 4) show that the contribution of
R* to the GTPase activity decreases with increasingFigure 4 Portion of R*, AorthoR* and BR* or CR*, in dependence of liga
state GTPase course. The profiles were calculated according to the equat
by fitting of the experimental data of Schnell and Seifert 2010, shown in Fihistamine concentration. In contrast, the contribution of
the active histamine-hH3R-complexes (CR*) to the
GTPase activity increases (Figure 4). Because the in-
crease of CR* is stronger, as the decrease of R*, the final
GTPase activity is increased with increasing histamine
concentration, which is in very good accordance to ex-
perimental results (Schnell and Seifert 2010). As pro-
vided by Figure 5, the calculated course of basal GTPase
activity or GTPase activity in presence of 10 μM hista-
mine or thioperamide in dependence of NaCl concentra-
tion is in very good accordance to the experimental data.
Calculation of the pEC50 values
Additionally, it is possible to deduce an equation for the
experimentally observed pEC50 value from the equations
(28 and 29) for thioperamide in dependence of the so-
dium ion concentration A0:nd concentration in GTP hydrolysis and the resulting steady-
ions 14, 16, 19, 23, 24 and 26 using the constants Kx (Table 1), obtained
gure 1, as described in Materials and Methods.
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http://www.in-silico-pharmacology.com/2/1/1pEC50 ¼ − log 1þ K 0 þ A0 K1 þ K0K2 þ K1K3ð ÞK4 þ K0K 5 þ A0K 1K 3K6
 
ð31Þ
and analogously for histamine:
pEC50 ¼ − log 1þ K 0 þ A0 K1 þ K0K2 þ K1K3ð ÞK7 þ K0K 8 þ A0K 1K 3K9
 
ð32Þ
These equations show that the pEC50 value is
dependent of the amount of constitutive activity, de-
scribed by K0 as well as of the constants K1, K2 and K3,
describing the three different equilibria between sodium
ions and the receptor (equations 2, 3, 4), and the con-
centration of sodium ion A0 itself. Furthermore, the lig-
and specific constants (thioperamide: K4, K5 and K6;
histamine: K7, K8 and K9) have an influence onto the
pEC50. The equations show that the pEC50 increases
with increase of the ligand-receptor specific constants
K4, K5, K6 (thioperamide) or K7, K8, K9 (histamine). Fur-
thermore, the pEC50 increases with decreasing K2. If no
sodium chloride is present, the constants K1, K2, K3, K6
(thioperamide) and K9 (histamine) are not relevant. Be-
cause of the complexity of the equations 31 and 32, the
influence of K0, K1, K3 and A0 onto the pEC50 depends
on the values of the other variables in the equations, and
thus, no simple rules to describe the influence of each
Kx onto pEC50 can be presented.
Using the Kx values, obtained by the fit of the experi-
mental data (Table 1), for the GTPase curve of thiopera-
mide in absence of NaCl, a pEC50 of 7.26 and in
presence of 100 mM NaCl, a pEC50 of 7.21 was obtained.
The pEC50 value in absence of sodium chloride fits well
to the experimental data (7.15 ± 0.31 (Schnell and Seifert
2010)). The calculated pEC50 value in presence of
100 mM NaCl does not differ within the limits of error
from the experimental data (7.43 ± 0.28 (Schnell and
Seifert 2010)). Using the Kx values, obtained by the fit of
the experimental data (Table 1), for the GTPase curve
of histamine in absence of NaCl, a pEC50 of 7.70 and in
presence of 100 mM NaCl, a pEC50 of 7.41 was ob-
tained. The pEC50 value in absence (exp.: 8.01 ± 0.39
(Schnell and Seifert 2010)) and presence (exp.: 7.53 ± 0.18
(Schnell and Seifert 2010)) of sodium chloride fit well to
the experimental data.
Molecular dynamics of different thioperamide- and
Na+-hH3R-complexes
In order to study the influence of a sodium ion in its
allosteric binding site onto the conformation of the
ligand-free inactive hH3R, two different MD simulations
were performed: On the one hand, one Na+ was placed
into its allosteric site, according to the crystal structuresof the A2A (Liu et al. 2012). For purpose of reference, an
identical system, except with the Na+ not located in the
allosteric binding site of the hH3R, but somewhere in
the aqueous extracellular part of the simulation box was
built. The MD simulations, performed under comparable
conditions, revealed a stabilization of the inactive con-
formation of the hH3R, with the sodium ion being stable
in its allosteric binding site. In contrast for the reference
system, without a Na+ in the allosteric pocket of hH3R,
after ~ 6 ns of simulation, the hH3R started to undergo a
conformational change especially in the intracellular part
of the receptor. Here, a slight outward movement of TM
VI was observed. Thus, the findings of the MD simula-
tions support the experimental findings that a sodium
ion, bound in its allosteric binding site stabilizes the in-
active conformation of hH3R.
In order to study the influence of a sodium ion in its
allosteric binding site onto the binding mode of thioper-
amide in its orthosteric binding site, two different MD
simulations were performed: On the one hand, one Na+
was placed into its allosteric site and one thioperamide
was placed into its orthosteric binding pocket. On the
other hand, one thioperamide was put into its orthos-
teric binding site, whereas no Na+ was located in the
allosteric binding site. The MD simulations, performed
under comparable conditions, revealed two different
binding modes of thioperamide. In presence of a Na+ in
the allosteric binding site, the imidazole moiety is lo-
cated “above” the highly conserved Asp3.32 (Figure 6A)
and the sodium ion remains stable in its allosteric site
(Figure 6A). In contrast, in absence of the Na+ in the
allosteric site, the imidazole moiety of thioperamide is
located below the highly conserved Asp3.32, in direction
to the highly conserved Asp2.50 (Figure 6B). As a conse-
quence of the missing compensation of the negative
charge of Asp2.50 by a sodium ion, the positively charged
imidazole moiety of thioperamide is attracted by Asp2.50.
However, in both cases, the thioperamide remains stable
in its orthosteric binding pocket.
An analysis of the fluctuation of the sodium ion in the
allosteric binding site in absence (Figure 7A) and pres-
ence (Figure 7B) of thioperamide in the orthosteric bind-
ing site is presented. In case that there is no ligand in
the orthosteric binding pocket, the sodium ion shows a
strong fluctuation between the Asp2.50 of the allosteric
and Asp3.32 of the orthosteric site (Figure 7A). In case
that the distance of the Na+ is with about 0.25 nm smal-
lest to one of the carboxy oxygens (OD1 or OD2) of
Asp2.50, the distance to one of the carboxy oxygens
(OD1 or OD2) of Asp3.32 is about 0.87 nm (Figure 7A).
In the other case, a distance of the Na+ to the Asp2.50 of
about 0.4 nm was observed, whereas the distance of the
Na+ to the Asp3.32 decreased to about 0.65 nm (Figure 7A).
In the absence of a ligand, the sodium ion switches its position
Figure 6 Binding mode of thioperamide to the orthosteric
binding site of hH3R. A, in presence of a sodium ion in the
allosteric binding site. Yellow circle: interaction of the imidazole
moiety of thioperamide with the highly conserved Asp3.32; orange
circle: a sodium ion in its allosteric binding site, interacting with
Ser3.39 and Asp2.50 B, in absence of a sodium ion in the allosteric
binding site. Yellow circle: interaction of the imidazole moiety of
thioperamide with the highly conserved Asp3.32, but compared to A)
located downwards in direction to Asp2.50. Shown are snapshots
after 5 ns of productive MD simulation.
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In contrast, if thioperamide is bound to the orthosteric
binding site, the sodium ion remains very stable near to
Asp2.50 and does not fluctuate between Asp2.50 and
Asp3.32 (Figure 7B). Thus, the modelling data indicate
that thioperamide in the orthosteric and Na+ in the allo-
steric site have a mutual influence to each other.An analysis of the positions of the chloride ions,
present in the simulation box, during the simulation re-
vealed no uniform distribution over the whole aqueous
phase. Instead, a higher probability of chloride ions be-
tween the TM domains of the intracellular part of the
hH3R relative to the remaining aqueous phase was ob-
served (Figure 8). Although the increased probability of
a chloride ion between the intracellular part of the TMs,
a stable binding of one and the same Cl- during more
than 300 ps of the simulation was not observed. Because
the intracellular part of the receptor is the target for the
C-terminus of the Gα subunit, this observation may
indicate that anions may have an influence onto the Gα-
binding process and therefore onto GTP hydrolysis.
Discussion
The results obtained in this study suggest that thiopera-
mide, known as inverse agonist, not only binds into the
inactive state hH3R, but also into the active hH3R. How-
ever, as suggested by the corresponding association con-
stants, the binding of thioperamide to the inactive hH3R
is preferred, compared to the binding to the active
hH3R. Furthermore, the present results indicate that his-
tamine, known as an agonist, not only binds to the active
state hH3R, but also to the inactive hH3R. But as sug-
gested by the corresponding association constants, the
binding of histamine to the active hH3R is preferred,
compared to the binding to the inactive hH3R. Thus,
this kind of data analysis presented in this study allows
to obtain information about association constants of a
ligand to the inactive and active state of a GPCR
separately.
In literature, the influence of different cations and an-
ions onto the signalling of various GPCRs is discussed
(Schetz and Sibley 2001; Swaminath et al 2002; Seifert
and Wenzel-Seifert 2001; Schnell and Seifert 2010). At
hH3R, the GTP hydrolysis in presence of 10 μM histamine
or 10 μM thioperamide or the basal GTP hydrolysis with-
out presence of a ligand was analyzed in dependence of the
concentration of different monovalent salts, like LiCl, LiBr,
LiJ, NaCl, NaBr, NaJ, KCl, KBr and KJ (Schnell and Seifert
2010). These data indicate that not only cations have an in-
fluence onto GPCR signalling, but also anions. Within the
MD simulations at hH3R, chloride ions were observed
more frequently at the intracellular side of the receptor.
This is in very good accordance to the fact that, compared
to the extracellular side of the hH3R, more positively
charged amino acids are located at the intracellular side of
the receptor. Although we could not detect a stable binding
of the same chloride at the intracellular part of hH3R over
several ns, we observed chloride ions binding for about
300 ps to positively charged amino acids of the hH3R, e.g.
Arg3.50 (Figure 8), for several times during the whole simu-
lation. This “sporadic” binding of a chloride ion may hinder
Figure 7 Distance of the Na+ in the allosteric binding site to Asp2.50 and Asp3.32. Shown are the data of representative 5 ns of MD simulation.
Figure 8 Cl- binding site between the TM domains of the
intracellular part of the hH3R. Shown are the positions of chloride
ions (green spheres) accumulated over the whole simulation time.
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a decreased basal activity with increasing concentration of
chloride or other ions. Additionally, an effect of anions dir-
ectly onto the G protein has to be considered (Higashijima
et al. 1987). Relevant anion binding sites at G proteins can
be identified within future studies by crystal structures or
MD simulations. However, in order to obtain a deeper
insight onto the influence of cations and anions onto GPCR
signalling, more experimental studies, combined with mod-
elling studies have to be performed. In this context it may
be of interest to study the influence of monovalent salts
onto the GPCR signalling of hH4R in more detail. Although
it was shown that the hH4R is insensitive to sodium ions
(Schneider and Seifert 2009), it may be useful to compare
two different receptors, coupling to one and the same G
protein in order to be able to separate between an effect of
ions onto the receptor or onto the G protein.
In general, functional data, e.g. obtained within the
steady-state GTPase assay are analyzed by determination of
the pEC50 value of a ligand. However, pEC50 values repre-
sent a complex quantity, consisting of distinct ligand- and/
or receptor specific contributions, as shown above. Thus, a
comprehensive explanation of pEC50 values on a molecular
level with the help of computational methods may be a
challenge. In contrast, if functional data will be analyzed
using the equations mentioned above, distinct equilibrium
constants, which can be related to results of molecular
modelling studies, can be obtained. For example, using the
present equations, it is possible to determine the binding
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via the orthosteric binding site into its allosteric bind-
ing site. It may be suggested that there are no signifi-
cant differences for the binding constant of the sodium
ion from the extracellular side into the orthosteric
binding pocket, because this process is mainly driven
by an electrostatic attraction of the positively charged
sodium ion and negatively charged amino acids in the
orthosteric binding pocket, like the highly conserved
Asp3.32. Thus, significant differences in the related
constants K1 or K2 between sodium sensitive and so-
dium insensitive GPCRs are not expected. Of course,
the binding of the sodium ion from the orthosteric to
the allosteric binding site is also suggested to be driven
by an electrostatic attraction between the sodium ion
and the highly conserved Asp2.50 in the allosteric bind-
ing site. However, a comparison of all amino acids,
forming the binding channel for the sodium ion from
the orthosteric to the allosteric binding site, between
the human aminergic GPCRs reveals distinct differ-
ences (Figure 9). Thus, it can be suggested that differ-
ences in amino acids between the human aminergic
GPCRs within this channel may have a large influence
onto sodium sensitivity, and consequently may have in-
fluence onto the constant K3, which corresponds to the
transition of the sodium ion from its orthosteric to its
allosteric binding site. Due to the differences in amino
acids in direct neighbourhood to the sodium binding
channel (Figure 9), it will be interesting to perform
similar studies, as presented within this work, at other
human aminergic GPCRs and to compare the resulting
constants K3. This may give a more detailed insight
onto the sodium sensitivity of GPCRs on a molecular
level. Furthermore, the constants K6 (here describingFigure 9 Sodium binding channel of an aminergic GPCR. A, Na+-bindin
B, Distribution of amino acids being in direct contact to the sodium bindinthe binding of thioperamide to the receptor with a so-
dium ion being in its allosteric binding pocket) and K9
(here describing the binding of histamine to the recep-
tor with a sodium ion being in its allosteric binding
pocket) are suggested to have an influence onto the
sodium sensitivity of a GPCR. In general, if a sodium
ion is bound in its allosteric binding site it has to be
taken into account that this may have an influence
onto the orthosteric ligand binding pocket, e.g. amino
side chains being located in near neighbourhood to the
allosteric and orthosteric binding site may change its
conformation in dependence of absence or presence of
a sodium ion in its allosteric site. Consequently this
may have influence onto the binding properties of a
ligand to its binding pocket. This hypothesis is sup-
ported by the MD simulations of thioperamide in the
inactive hH3R (Figure 6). The results suggest that the
binding mode of thioperamide is dependent of the
absence or presence of a sodium ion in the allosteric
pocket.
Conclusion
In this study we developed a mathematical model to
describe the sensitivity of GPCRs to sodium ions in
presence or absence of a ligand. The excellent quality
of the new mathematical model, consisting of a couple
equilibrium constants, was shown by fitting experi-
mental data obtained with the steady-state GTPase
assay at hH3R. On the one hand, the new mathematical
model allows a more detailed insight onto the ligand-
and Na+ binding processes to a GPCR on a molecular
level. On the other hand, the model may be extended
to the quantitative description of arbitrary ligand-ion-
receptor-binding processes.g channel of an aminergic GPCR with highly conserved amino acids.
g channel of all human aminergic GPCRs.
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